Global Plasmid Purification Market Size study, by Offering, by Grade, by Application, by End-use and Regional Forecasts 2022-2032

Description

Global Plasmid Purification Market was valued at approximately USD 1.78 billion in 2023, exhibiting a robust CAGR of 11.69% throughout the forecast period from 2024 to 2032. Plasmid purification has emerged as a cornerstone in molecular biology, underpinning a wide array of applications such as gene cloning, genetic engineering, and gene expression studies. This sophisticated process is integral for obtaining high-quality plasmid DNA, which is indispensable for downstream applications including sequencing, transformation, and polymerase chain reactions (PCR). The integrity and purity of plasmid DNA directly influence the success of experiments, especially in transfection assays where gene expression efficiency is paramount. Consequently, the adoption of advanced plasmid purification technologies, which ensure the removal of impurities and deliver high-yield, high-purity plasmid DNA, is on the rise.

The Global Plasmid Purification Market is driven by burgeoning demand for recombinant DNA technology products, coupled with the continuous advancements in purification techniques, serves as a major driving force for market growth. Moreover, the increasing acceptance and implementation of cell and gene therapies in treating chronic diseases further bolster the expansion of this market. However, costs associated with advanced purification methods and regulatory and ethical challenges in gene therapy is going to impede the overall demand for the market during forecast period 2022-2032.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America, with its leading-edge research facilities, government funding, and commercial demand for molecular cloned products, dominated the market. This region benefits from extensive investments in cell and gene therapy research and development, positioning it as a leader in this space. Futhermore, the Asia Pacific region is poised to experience the fastest growth over the forecast period. Factors such as the rising prevalence of chronic diseases, expanding research activities in genetic engineering, and the growing adoption of gene therapies in this region contribute to its rapid market expansion.

Major market players included in this report are:

Merck KGaA
QIAGEN
Thermo Fisher Scientific, Inc.
Takara Bio
Promega Corporation
Zymo Research
MP Biomedicals
New England Biolabs
MCLAB
Applied Biological Materials Inc.

The detailed segments and sub-segment of the market are explained below:

By Offering

Products
Services

By Grade

Molecular Grade
Transfection Grade

By Application

Cloning & Protein Expression
Transfection & Gene Editing
Others

By End-use

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Plasmid Purification Market Executive Summary

1.1. Global Plasmid Purification Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Offering
- 1.3.2. By Grade
- 1.3.3. By Application
- 1.3.4. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Plasmid Purification Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Plasmid Purification Market Dynamics

3.1. Market Drivers
- 3.1.1. Growing demand for recombinant DNA technology products
- 3.1.2. Advancements in plasmid purification techniques
- 3.1.3. Rising acceptance of cell and gene therapy
3.2. Market Challenges
- 3.2.1. High costs associated with advanced purification methods
- 3.2.2. Regulatory and ethical challenges in gene therapy
3.3. Market Opportunities
- 3.3.1. Expansion in Asia Pacific due to rising biotechnology investments
- 3.3.2. Innovations in purification technologies
- 3.3.3. Strategic collaborations and partnerships in the biotechnology sector

Chapter 4. Global Plasmid Purification Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Plasmid Purification Market Size & Forecasts by Offering 2022-2032

5.1. Segment Dashboard
5.2. Global Plasmid Purification Market: Offering Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Products
- 5.2.2. Services

Chapter 6. Global Plasmid Purification Market Size & Forecasts by Grade 2022-2032

6.1. Segment Dashboard
6.2. Global Plasmid Purification Market: Grade Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Molecular Grade
- 6.2.2. Transfection Grade

Chapter 7. Global Plasmid Purification Market Size & Forecasts by Application 2022-2032

7.1. Segment Dashboard
7.2. Global Plasmid Purification Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Cloning & Protein Expression
- 7.2.2. Transfection & Gene Editing
- 7.2.3. Others

Chapter 8. Global Plasmid Purification Market Size & Forecasts by End-use 2022-2032

8.1. Segment Dashboard
8.2. Global Plasmid Purification Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Pharmaceutical & Biotechnology Companies
- 8.2.2. Academic & Research Institutes
- 8.2.3. Contract Research Organizations

Chapter 9. Global Plasmid Purification Market Size & Forecasts by Region 2022-2032

9.1. North America Plasmid Purification Market
- 9.1.1. U.S. Plasmid Purification Market
  - 9.1.1.1. Offering breakdown size & forecasts, 2022-2032
  - 9.1.1.2. Grade breakdown size & forecasts, 2022-2032
  - 9.1.1.3. Application breakdown size & forecasts, 2022-2032
  - 9.1.1.4. End-use breakdown size & forecasts, 2022-2032
- 9.1.2. Canada Plasmid Purification Market
  - 9.1.2.1. Offering breakdown size & forecasts, 2022-2032
  - 9.1.2.2. Grade breakdown size & forecasts, 2022-2032
  - 9.1.2.3. Application breakdown size & forecasts, 2022-2032
  - 9.1.2.4. End-use breakdown size & forecasts, 2022-2032
9.2. Europe Plasmid Purification Market
- 9.2.1. U.K. Plasmid Purification Market
- 9.2.2. Germany Plasmid Purification Market
- 9.2.3. France Plasmid Purification Market
- 9.2.4. Spain Plasmid Purification Market
- 9.2.5. Italy Plasmid Purification Market
- 9.2.6. Rest of Europe Plasmid Purification Market
9.3. Asia-Pacific Plasmid Purification Market
- 9.3.1. China Plasmid Purification Market
- 9.3.2. India Plasmid Purification Market
- 9.3.3. Japan Plasmid Purification Market
- 9.3.4. Australia Plasmid Purification Market
- 9.3.5. South Korea Plasmid Purification Market
- 9.3.6. Rest of Asia Pacific Plasmid Purification Market
9.4. Latin America Plasmid Purification Market
- 9.4.1. Brazil Plasmid Purification Market
- 9.4.2. Mexico Plasmid Purification Market
- 9.4.3. Rest of Latin America Plasmid Purification Market
9.5. Middle East & Africa Plasmid Purification Market
- 9.5.1. Saudi Arabia Plasmid Purification Market
- 9.5.2. South Africa Plasmid Purification Market
- 9.5.3. Rest of Middle East & Africa Plasmid Purification Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Merck KGaA
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Market Strategies
- 10.3.2. QIAGEN
- 10.3.3. Thermo Fisher Scientific, Inc.
- 10.3.4. Takara Bio
- 10.3.5. Promega Corporation
- 10.3.6. Zymo Research
- 10.3.7. MP Biomedicals
- 10.3.8. New England Biolabs
- 10.3.9. MCLAB
- 10.3.10. Applied Biological Materials Inc.

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes